These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23450331)
1. Association of lipid peroxidation with endothelial dysfunction in patients with overt hypothyroidism. Tejovathi B; Suchitra MM; Suresh V; Reddy VS; Sachan A; Srinivas Rao PV; Bitla AR Exp Clin Endocrinol Diabetes; 2013 May; 121(5):306-9. PubMed ID: 23450331 [TBL] [Abstract][Full Text] [Related]
2. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709 [TBL] [Abstract][Full Text] [Related]
3. Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism. Arpaci D; Karakece E; Tocoglu AG; Ergenc H; Gurol G; Ciftci IH; Tamer A Ann Clin Lab Sci; 2016 Dec; 46(6):601-607. PubMed ID: 27993872 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of protein oxidation and its association with lipid peroxidation and thyrotropin levels in overt and subclinical hypothyroidism. Haribabu A; Reddy VS; Pallavi Ch; Bitla AR; Sachan A; Pullaiah P; Suresh V; Rao PV; Suchitra MM Endocrine; 2013 Aug; 44(1):152-7. PubMed ID: 23224563 [TBL] [Abstract][Full Text] [Related]
5. Supplementation of a γ-tocopherol-rich mixture of tocopherols in healthy men protects against vascular endothelial dysfunction induced by postprandial hyperglycemia. Mah E; Noh SK; Ballard KD; Park HJ; Volek JS; Bruno RS J Nutr Biochem; 2013 Jan; 24(1):196-203. PubMed ID: 22841396 [TBL] [Abstract][Full Text] [Related]
6. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Yilmaz MI; Saglam M; Caglar K; Cakir E; Sonmez A; Ozgurtas T; Aydin A; Eyileten T; Ozcan O; Acikel C; Tasar M; Genctoy G; Erbil K; Vural A; Zoccali C Am J Kidney Dis; 2006 Jan; 47(1):42-50. PubMed ID: 16377384 [TBL] [Abstract][Full Text] [Related]
7. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression. Selley ML J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938 [TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Rajendran S; Willoughby SR; Chan WP; Liberts EA; Heresztyn T; Saha M; Marber MS; Norman RJ; Horowitz JD Atherosclerosis; 2009 Jun; 204(2):509-14. PubMed ID: 19027116 [TBL] [Abstract][Full Text] [Related]
9. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease. Sahin M; Arslan C; Naziroglu M; Tunc SE; Demirci M; Sutcu R; Yilmaz N Ann Clin Lab Sci; 2006; 36(4):449-54. PubMed ID: 17127734 [TBL] [Abstract][Full Text] [Related]
10. Postprandial hyperglycemia impairs vascular endothelial function in healthy men by inducing lipid peroxidation and increasing asymmetric dimethylarginine:arginine. Mah E; Noh SK; Ballard KD; Matos ME; Volek JS; Bruno RS J Nutr; 2011 Nov; 141(11):1961-8. PubMed ID: 21940510 [TBL] [Abstract][Full Text] [Related]
11. Abnormal endothelial function in female patients with hypothyroidism and borderline thyroid function. Dagre AG; Lekakis JP; Protogerou AD; Douridas GN; Papaioannou TG; Tryfonopoulos DJ; Papamichael CM; Alevizaki M Int J Cardiol; 2007 Jan; 114(3):332-8. PubMed ID: 16793150 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction. McCarty MF Med Hypotheses; 2004; 63(4):699-708. PubMed ID: 15325021 [TBL] [Abstract][Full Text] [Related]
14. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism. Ozcan O; Cakir E; Yaman H; Akgul EO; Erturk K; Beyhan Z; Bilgi C; Erbil MK Clin Endocrinol (Oxf); 2005 Aug; 63(2):203-6. PubMed ID: 16060915 [TBL] [Abstract][Full Text] [Related]